All-trans retinoic acid combined with interferon-alpha effectively inhibits granulocyte-macrophage colony formation in chronic myeloid leukemia

Leukemia Research

Volumn 20, Issue 3, 1996, Pages 243-248

  Zheng, Aiping ^a   Savolainen, Eeva Riitta ^a   Koistinen, Pirjo ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

ATRA; CFU GM; CML; IFN ; MPDs

Indexed keywords

ALPHA INTERFERON; RETINOIC ACID;

ADULT; AGED; ARTICLE; CELL GROWTH; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; COLONY FORMATION; COLONY FORMING UNIT GM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; MALE; MYELOPROLIFERATIVE DISORDER; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL;

EID: 0029862938     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/0145-2126(95)00148-4     Document Type: Article

References (27)

1. Sporn M. B. & Roberts A. B. (1983) Role of retinoids in differentiation and carcinogenesis. Cancer Res. 43, 3034.
2. Warrell R. P. Jr (1994) Applications for retinoids in cancer therapy. Semin. Hematol. 31(Suppl. 5), 1.
3. Bretiman T. R., Selonick S. E. & Collins S. J. (1980) Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. natn. Acad. Sci. USA 77, 2936.
4. Breitman T. R., Colins S. J. & Keene B. R. (1981) Terminal differentiation of human promyelocytic leukemia cells in primary culture in response to retinoic acid. Blood 57, 1000.
5. Huang M. E., Ye Y. C., Chen S. R., Chai J. R., Lu J. X., Zhao L., Gu L. J. & Wang Z. Y. (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72, 567.
6. Fenaux P. (1993) Management of acute promyelocytic leukemia. Eur. J. Haematol. 50, 65.
7. Bollag W. (1991) Retinoids and interferon: a new promising combination? Br. J. Haematol. 79, 87.
8. Moore D. M., Kalvakolanu D. V., Lippman S. M., Kavanagh J. J., Hong W. K., Burden E. C., Paredes-Espinoza M. & Krakoff I. H. (1994) Retinoic acid and interferon in human cancer: mechanistic and clinical studies. Semin. Hematol. 31(Suppl. 5), 31.
9. Lippman S. M., Glisson B. M., Kavanagh J. J., et al. (1993) Retinoic acid and interferon combination studies in human cancer. Eur. J. Cancer 29A(Suppl. 15), 9.
10. Talpaz M., Kantarjian H. M., McCredie K., et al. (1986) Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha in chronic myelogenous leukemia. N. Engl. J. Med. 314, 1065.
11. Kantarjian H. M., Deisseroth A., Kurzrock R., Estrov Z. & Talpaz M. (1993) Chronic myelogenous leukemia: a concise update. Blood 82, 691.
12. The Italian Cooperative Study Group on Chronic Myeloid Leukemia (1994) Interferon-α 2a as compared with conventional chemotherapy for the treatment of CML. N. Engl. J. Med. 330, 820.
13. Douer D. & Koeffler H. P. (1982) Retinoic acid enhances colony-stimulating factor-induced clonal growth of normal human myeloid progenitor cells in vitro. Expl Cell Res. 138, 193.
14. Bradley E. C., Ruscetti F. W., Steinberg H., Paradise C. & Blaine K. (1983) Inhibition of differentiation and proliferation of colony-stimulating factor-induced clonal growth of normal human marrow cells in vitro by retinoic acid. J. natn. Cancer Inst. 71, 1189.
15. Gratas C., Menot M. L., Dresch C. & Chomienne C. (1993) Retinoid acid supports granulocytic but not erythroid differentiation of myeloid progenitors in normal bone marrow cells. Leukemia 7, 1156.
16. Bockstaele D. R. van, Lenjou M., Snoeck H. W., Lardon F., Stryckmans P. & Petermans M. E. (1993) Direct effects of 13-cis and all-trans retinoic acid on normal bone marrow (BM) progenitors: comparative study on BM mononuclear cells and on isolated CD34+ BM cells. Ann. Hematol. 66, 61.
17. Rowley J. D. (1973) A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243, 290.
18. Wasserman L. R. (1971) The management of polycythaemia vera. Br. J. Haematol. 21, 371.
19. Hoffman R. & Silverstein M. N. (1991) Agnogenic myeloid metaplasia. In Hematology, Basic Principles and Practice (Hoffman R., Bentz E. J. Jr, Shattil S. J., Furie B. & Cohen H. J., Eds), p. 870. Churchill Livingstone, New York.
20. Hoffman R. & Silverstein M. N. (1991) Primary thrombocythaemia. In Hematology, Basic Principles and Practice (Hoffman R., Bentz E. J. Jr, Shattil S. J., Furie B. & Cohen H. J., Eds), p. 881. Churchill Livingstone, New York.
21. Böyum A. (1968) Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. 21(Suppl. 97), 77.
22. Buick R. D., Till J. E. & McCulloch E. A. (1977) Colony assay for proliferative blast cells circulating in myeloblastic leukemia. Lancet i, 862.
23. Emanuel P. D., Zuckerman K. S., Wimmer R., Cohn S., Chaffee S. & Castleberry R. P. (1991) In vivo 13-cis retinoic acid therapy decreases the in vitro GM-CSF hypersensitivity in juvenile chronic myelogenous leukemia (JCML). Blood 78(Suppl. 1), 170a.
24. Castleberry R. P., Emanuel P. D., Zuckerman K. S., Cohn S., Strauss L., Byrd R. L., Hoams A., Chaffee S., Nitschke R. & Gualtieri R. J. (1994) A pilot study of isotretinoin in the treatment of juvenile chronic myelogenous leukemia. N. Engl. J. Med. 331, 1680.
25. Mundle S., Samie A., Chaney C., Shott S., Shetty V., Alvi S., Showel J., Gregory S., Rifkin S., Loew J., Larson R., Goldberg J., Preisler H. & Raza A. (1994) In vivo effects of retinoic acid (RA) and alpha interferon (IFN-α) on proliferation and apoptosis in marrows of acute myelogenous leukemia (AML) patients. Blood 84(Suppl. 1), 312a.
26. Nilsson B., Olofsson T. & Olsson I. (1984) Myeloid differentiation in liquid cultures of cells from patients with chronic myeloid leukemia: effects of retinoic acid and indomethacin. Expl Hematol. 12, 91.
27. Sagayadan G. E., Wiernik P. H., Sun N., Ahearn G., Thompson D., Hallam S. J., Hu X. P., Dutcher J. P. & Gallagher R. E. (1994) Effect of retinoic acid and interferon alpha on granulocyte-macrophage colony forming cells in chronic myeloid leukemia; increased inhibition by all-trans and 13-cis-retinoic acids in advanced stage disease. Leukemia Res. 18, 741.